Operating Lease, Right-of-Use Asset in USD of Talis Biomedical Corp from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Talis Biomedical Corp quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2020 to Q2 2024.
  • Talis Biomedical Corp Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2024 was $7.91M, a 50.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Talis Biomedical Corp Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 $7.91M -$8.12M -50.7% 30 Jun 2024 10-Q 19 Aug 2024
Q1 2024 $8.15M -$4.14M -33.6% 31 Mar 2024 10-Q 08 May 2024
Q4 2023 $12.4M -$18.5M -59.8% 31 Dec 2023 10-Q 19 Aug 2024
Q3 2023 $12.8M -$22.3M -63.4% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $16M -$19.8M -55.2% 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 $12.3M -$404K -3.18% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $30.9M +$18M +140% 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 $35.1M +$21.7M +162% 30 Sep 2022 10-Q 03 Nov 2022
Q2 2022 $35.8M +$22M +160% 30 Jun 2022 10-Q 02 Aug 2022
Q1 2022 $12.7M +$12.3M +3073% 31 Mar 2022 10-Q 10 May 2022
Q4 2021 $12.9M +$12.3M +2176% 31 Dec 2021 10-K 22 Mar 2023
Q3 2021 $13.4M 30 Sep 2021 10-Q 16 Nov 2021
Q2 2021 $13.7M 30 Jun 2021 10-Q 10 Aug 2021
Q1 2021 $400K 31 Mar 2021 10-Q 13 May 2021
Q4 2020 $567K 31 Dec 2020 10-K 15 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.